Adjusting a polymer formulation for an optimal bioresorbable stent: A 6-month follow-up study

EuroIntervention

Volumn 8, Issue 2, 2012, Pages 242-249

  Durand, Eric ^a   Lemitre, Mathilde ^a   Couty, Ludovic ^a   Sharkawi, Tahmer ^b   Brasselet, Camille ^a   Vert, Michel ^c   Lafont, Antoine ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

Bioresorbable; Inflammation; Poly(lactic acid); Restenosis; Stent; Stereo copolymers

Indexed keywords

COPOLYMER; POLYLACTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DISEASE; ARTICLE; BIOCOMPATIBILITY; BIOMECHANICS; CELL PROLIFERATION; CONTROLLED STUDY; EQUIPMENT DESIGN; EXPERIMENTAL STUDY; FOLLOW UP; HEART VENTRICLE HYPERTROPHY; ILIAC ARTERY OBSTRUCTION; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; MATERIALS TESTING; MORPHOMETRICS; NEOINTIMAL HYPERPLASIA; NONHUMAN; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POLYMERIZATION; RABBIT; STENT; TREATMENT RESPONSE;

ANGIOPLASTY; ANIMALS; BIOMECHANICS; FOLLOW-UP STUDIES; ILIAC ARTERY; LACTIC ACID; MALE; POLYMERS; RABBITS; STENTS;

EID: 84865588578     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV8I2A38     Document Type: Article

References (26)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994;331:489-95. (Pubitemid 24256751)
2. Vert M. Degradable and bioresorbable polymers in surgery and in pharmacology: beliefs and facts. J Mater Sci Mater Med. 2009;20:437-46.
3. Sharkawi T, Cornhill F, Lafont A, Sabaria P, Vert M. Intravascular bioresorbable polymeric stents: a potential alternative to current drug eluting metal stents. J Pharm Sci. 2007;96:2829-37. (Pubitemid 350221186)
4. Onuma Y, Serruys PW. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation. 2011;123:779-97.
5. Vert M. Bioabsorbable polymers in medicine: an overview. EuroIntervention. 2009:5 Suppl F:F9-F14.
6. Vert M. Poly(lactic acid)s, in Doi Y, editor. Encyclopedia of biomaterials and biomedical engineering. 1st edition. New York: Marcel Dekker, Inc., New York; 2004, p.1254-1263.
7. Vert M. Lactic and glycolic acid-based bioresorbable polymeric materials in ACL reconstruction, in Williams RJ, Johnson DP, editors. Controversies in Knee Surgery. Oxford: Oxford University Press; 2004, p.97-108.
8. Vert M, Chabot F, Leray J, Christel P. Bioresorbable polyesters for bone surgery. Makromolekulare Chemie. 1981;Suppl. 5:30-41.
9. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, Komori H, Tsuji T, Motohara S, Uehata H. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation. 2000;102:399-404. (Pubitemid 30490677)
10. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet. 2008;371:899-907. (Pubitemid 351384734)
11. Tanimoto S, Serruys PW, Thuesen L, Dudek D, de Bruyne B, Chevalier B, Ormiston JA. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials. Catheter Cardiovasc Interv. 2007;70:515-23. (Pubitemid 47597022)
12. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel- Hébert K, Veldhof S, Webster M, Thuesen L, Dudek D. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373:897-910.
13. Onuma Y, Serruys PW, Perkins LEL, Okamura T, Gonzalo N, García-García HM, Regar E, Kamberi M, Powers JC, Rapoza R, van Beusekom H, van der Giessen W, Virmani R. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB Trial. Circulation. 2010;122:2288-300.
14. Onuma Y, Garg S, Okamura T, Ligthart J, van Geuns RJ, de Feyter PJ, Serruys PW, Tamai H. Ten-year follow-up of the IGAKITAMAI stent. EuroIntervention. 2009;5 Suppl F:F109-11.
15. Dos Santos I, Morgat JL, Vert M. A route to high radioactivity 3H-labelled PLA polymers. Polymer International. 1999;48:283-7.
16. Vert M, Dos Santos I, Ponsart S, Alauzet N, Morgat JL, Coudane J, Garreau H. Degradable polymers in a living environment: Where do you end up? Polymer International. 2002;51:840-4. (Pubitemid 35337587)
17. Vert M, Christel P, Chabot F, Leray J. Bioresorbable plastic materials for bone surgery, in Hastings GW, Ducheyne P, editors. Macromolecular Biomaterials. New York: CRC / Press Inc.; 1984. p. 119-41.
18. Lafont A, Li S, Garreau H, Cornhill F, Vert M. PLA stereocopolymers as sources of bioresorbable stents: preliminary investigation in rabbit. J Biomed Mater Res B Appl Biomater. 2006;77:349-56. (Pubitemid 43667458)
19. Brasselet C, Durand E, Addad F, Vitry F, Chatellier G, Demerens C, Lemitre M, Garnotel R, Urbain D, Bruneval P, Lafont A. Effect of local heating on restenosis and in-stent neointimal hyperplasia in the atherosclerotic rabbit model: a dose-ranging study. Eur Heart J. 2008;29:402-12. (Pubitemid 351197759)
20. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol. 1992;19:267-74.
21. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Kolodgie FD, Virmani R. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 2008;52:333-42. (Pubitemid 352001347)
22. Tanimoto S, Bruining N, van Domburg RT, Rotger D, Radeva P, Ligthart JM, Serruys PW. Late stent recoil of the bioabsorbable everolimus-eluting coronary stent and its relationship with plaque morphology. J Am Coll Cardiol. 2008;52:1616-20.
23. Vorpahl M, Finn AV, Nakano M, Virmani R. The bioabsorption process: tissue and cellular mechanisms and outcomes. EuroIntervention. 2009;5 Suppl F:F28-35.
24. Lafont A, Durand E. A.R.T.: concept of a bioresorbable stent without drug elution. EuroIntervention. 2009;5 Suppl F:F83-7.
25. van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DR Jr, Ellis SG, Topol EJ. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation. 1996;94:1690-7. (Pubitemid 26320276)
26. Vogt F, Stein A, Rettemeier G, Krott N, Hoffmann R, vom Dahl J, Bosserhoff AK, Michaeli W, Hanrath P, Weber C, Blindt R. Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent. Eur Heart J. 2004;25:1330-40. (Pubitemid 38998510)